Predictors of response for mood stabilizers in bipolar affective disorders;Wirksamkeitspradiktoren fur phasenprophylaktika (stimmungsstabilisierer) bei bipolaren affektiven storungen

Fortschritte der Neurologie Psychiatrie

Volumn 67, Issue 2, 1999, Pages 75-80

  Walden, Jörg ^a   Normann, C ^b   Langosch, J ^b   Grunze, H ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; VALPROIC ACID; TRANQUILIZER;

ARTICLE; DEPRESSION; DRUG EFFICACY; DYSPHONIA; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PREDICTION; TREATMENT PLANNING; AFFECT; BIPOLAR DISORDER; DRUG EFFECT; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW;

AFFECT; ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS;

EID: 0033041218     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993984     Document Type: Article

References (62)

1. Akiskal, H. S.: The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J. Clin. Psychopharmacol. 16, suppl. 1 (1996) 4S -14S
2. Blier, P., C. de Montigny: Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994) 220-226
3. Bowden, C. L.: Predictors of response to divalproex and lithium. J. Clin. Psychiatry 56, Suppl. 3, (1995) 25-30
4. Calabrese, J., G. A. Delucchi: Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder. Am. J. Psychiatry 147 (1990) 431-434
5. Calabrese, J. R., M. J. Woyshville, S. E. Kimmel, D. J. Rapport: Predictors of valproate response in bipolar rapid cycling. J. Clin. Psychopharmacology 13 (1993) 280-283
6. Calabrese, J., C. Bowden, M. J. Woyshville: Lithium and anticonvulsants in bipolar disorder. In: Bloom, F., D. Kupfer (Hrsg.), Psychopharmacology, the fourth generation of progress. New York, Raven Press, 1099-1111, 1994
7. Calabrese, J., S. H. Fatemi, M. Kujawa, M. J. Woyshville: Predictors of response to mood stabilizers. J. Clin. Psychopharmacology 16, Suppl. 1 (1996) 24S-31S
8. Calabrese, J., D. J. Rapport, M. Shelton, M. Kujawa, S. Kimmel: Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology 38 (1998) 185-191
9. Clothier, J. L., P. J. Pazzaglia, T. Freeman, M. Davidlesen, A. C. Swann: Plasma level response characteristics of valproate in the treatment of manic syndrome. Ann. Of. Clin. Psychiatry 3 (1991) 321-324
10. Davis, L. L., D. Kabel, D. Patel, A. D. Choate, C. Foslien-Nash, N. M. Gurgis, G. Kramer, F. Petty: Valproate as an antidepressant in major depressive disorder. Psychopharmacology Bulletin 32 (1996) 647-652
11. Dunner, D. L., R. R. Fieve: Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psychiatry 30 (1974) 229-233
12. Erfurth, A., C. Kammerer, H. Grunze, C. Normann, J. Walden: An open label study of gabapentin in the treatment of acute mania. J. Psychiatr. Res. (1998) 261-264
13. Faedda, G. L., R. J. Baldessarini, M. Tohen: Episode sequence of bipolar disorder and response to lithium. A. J. Psychiatry 148 (1991) 1237-1239
14. Fatemi, S., D. Rapport, J. R. Calabrese, P. Thuras: Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry 58 (1997) 522-527
15. Fawcett, J., W. Scheftner, L. Fogg, D. C. Clark, M. A. Young, D. Hedeker, R. Gibbons: Time related predictors of suicide in major affective disorder. Am. J. Psychiatry 147 (1990) 1189-1194
16. Ferrier, I. N.: Lamotrigine and gabapentin. Alternatives in the treatment of bipolar disorder. Neuropsychobiology 38 (1998) 192-197
17. Freeman, T. W., J. L. Clothier, P. Pazzaglia, M. D. Lesem, A. C. Swann: A double blind comparison of valproate, lithium in the treatment of acute mania. Am. J. Psychiatry 149 (1992) 108-111
18. Freye, M., L. L. Altshuler, M. P. Szuba, N. Finch, J. Mintz: J. Clin. Psychiatry 57 (1996) 17-21
19. Fritze, J., M. Beneke, M. Lanczik, B. Schneider, J. Walden: Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorder. Pharmacopsychiatry, 27 (1994) 181-185
20. Gitlin, M. J., J. Swendsen, T. L. Heller, C. Hammen: Relapse and impairement in bipolar disorder. Am. J. Psychiatry 152 (1995) 1635-1640
21. Goodwin, F. K., K. R. Jamison: Manic-depressive illness. Oxford University Press, New York, 1990
22. Grof, P., J. Angst, M. Karasek, G. Keituer: Patient selection for long term lithium treatment in clinical practice. Arch. Gen. Psychiatry 36 (1979) 894-897
23. Grunze, H. J. Walden: Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs. Magnesium Res. 10 (1997) 119-126
24. Grunze, H., H. J. Möller, J. Walden, T. M. Meyer, R. W. Greene: Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current. Brain Res. 791 (1998a) 330-334
25. Grunze, H., A. Erfurth, B. Amann, G. Giupponi, C. Kammerer, J. Walden: Intravenous valproate loading in acutely manic and depressed bipolar patient. J. Clin. Psychopharmacol. (1998a) im Druck
26. Hellwig, B., B. Heßlinger, J. Walden: Acute brain syndrome after tappering off clozapine in clozapine-lithium combination. Prog. Neuropsychopharmacol & Biol. Psychiat., 20 (1996) 179-183
27. Hesslinger, B., C. Normann, J. Langosch, P. Klose, M. Berger, J. Walden: Effects of carbamazepine and valproate on haloperidol plasma levels and psychopathological outcome in schizophrenic patients. J. Clin. Psychopharmacology (1998) im Druck
28. Himmelhoch, J. M., M. E. Garfinkel: Mixed mania: diagnosis and treatment. Psychopharmacology Bulletin 22 (1986) 613-620
29. Janicak, P. G., R. Newman, J. M. Davis: Advances in the treatment of mania related disorders: a reappraisal. Psychiatry. Ann. 22 (1992) 92-103
30. Joyce, P. R.: Carbamazepine in rapid cycling bipolar affective disorder. Int. Clin. Psychopharmacol. 3 (1988) 123-129
31. Keck, P. E., S. L. McElroy: Treatment of bipolar disorder with lithium. Psychiatric Annals 23 (1993) 1-6
32. Ketter, T. A., R. Post, K. Worthington: Principles of clinically important drug interactions with carbamazepine. J. Clin. Psychopharmacology 11 (1991) 198-203
33. Ketter, T. A., P. Pazzaglia, R. Post: Synergy of carbamazepine and valproic acid in affective illness: case report and review of literature. J. Clin. Psychopharmacol. 12 (1992) 276-282
34. Kukopulos, A., D. Reginaldi, P. Laddomada, G. Floric, G. Serra, L. Tondo: Course of the manic depressive cycle and changes caused by treatment. Pharmacopsychiatry 13 (1980) 156-167
35. Kusumakar, V., L. N. Yathan: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 72 (1997) 145-148
36. Lerer, B., N. Moore, E. Meyendorff, S. Cho, S. Gershon: Carbamazepine vs lithium in mania: a double blind study. J. Clin. Psychiatry 48 (1987) 89-93
37. Maj, M., R. Pirozzi, F. Starace: Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J. Affective Disorders 17 (1989) 237-241
38. McElroy, S. L., P. E. Keck, H. G. Pope: Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am. J. Psychiatry 149 (1992) 1633-1644
39. Müller-Oerlinghausen, B., W. Greil, A. Berghöfer (Hrsg.): Die Lithiumtherapie. Nutzen-Risiken-Alternativen. Springer Verlag, Heidelberg, 2. Auflage, 1997
40. Normann, C., P. Klose, B. Hesslinger, J. Langosch, M. Berger, J. Walden: Haloperidol plasma levels and psychopathology in schizophrenic patients with antiepileptic co-medication. Pharmacopsychiatry 30 (1997) 204
41. Okuma, T.: Effects of carbamazepine and lithium in affective disorders. Neuropsychobiology 27 (1993) 138-145
42. Post, R., D. Rubonow, T. Uhde, P. P. Roy-Byrne, M. Linnoila, A. Rosoff, R. Cowdry: Dysphoric mania: clinical and biological correlates. Arch. Gen. Psychiatry 46 (1989) 353-358
43. Post, R.: Non-lithium treatment for bipolar disorder. J. Clin. Psychiatry 51, Suppl. 8 (1990) 9-16
44. Post, R., K. Denicoff, G. Lverich, M. A. Frye: Drug-induced switching in bipolar disorder. CNS Drugs 8 (1997) 352-365
45. Prien, R. F., J. M. Himmelhoch, D. J. Kupfer: Treatment of mixed mania. J. Affective Disorders 15 (1988) 9-15
46. Regier, D., M. Farmer, D. Rae, B. Locke, S. J. Keith, L. L. Judd, F. K. Goodwin: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 21 (1990) 2511-2518
47. Rey, A. C., D. C. Jimerson, R. M. Post: Lithium and electrolytes in cerebrospinal fluid of affectively ill patients during acute and chronic lithium treatment. Comm. Psychopharmacology 3 (1979) 267-278
48. Sachs, G. S.: Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J. Clin. Psychopharmacology 16, Supp. 1 (1996) 32S-47S
49. Secunda, S. K., A. Swann, M. M. Katz, J. Croughan, S. Chang: Diagnosis and treatment of mixed mania. Am. J. Psychiatry 44 (1987) 96-98
50. Sharma, V., E. Persad, D. Mazmanian: Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can. J. Psychiatry 38 (1993) 137-139
51. Stokes, P. E., C. Shamoina, P. Stoll: Efficacy of lithium as acute treatment of manic depressive illness. Lancet 1 (1971) 1319-1325
52. Stoll, A. L., M. Banov, M. Kolbrener, P. Mayer, M. Tohen, S. Strakowski, J. Castillo, T. Suppes, B. M. Cohen: Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J. Clin. Psychopharmacology 14 (1994) 311-313
53. Swann, A. C., C. Bowden, D. Morris, J. Calabrese, F. Petty, J. Small, S. Dilsaver, J. Davis: Depression during mania. Arch. Gen. Psychiatry 54 (1997) 37-42
54. Tohen, M., J. Castillo, H. Pope, J. Herbstein: Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J. Clin. Psychopharmacology 14 (1994) 67-70
55. Van Valkenburg, C., J. Kluznik, R. Merrill, W. Erickson: Therapeutic levels of valproate for psychosis. Psychopharmacology Bulletin 26 (1990) 254-255
56. Walden, J., H. Grunze, D. Bingmann, Z. Liu, R. Düsing: Calciumantagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies. Eur. J. Neuropsychopharmacol. 2 (1992) 455-462
57. Walden, J., H. Grunze, A. Mayer, R. Düsing, K. Schirrmacher, Z. Liu, D. Bingmann: Calciumantagonistic effects of carbamazepine in epilepsies and affective psychoses. Neuropsychobiology 27 (1993a) 171-175
58. Walden, J., U. Altrup, H. Reith, E.-J. Speckmann: Effect of valproate on early and late potassium currents of single neurons. Eur. Neuropsychopharmacology 3 (1993b) 137-141
59. Walden J., B. Hesslinger: Bedeutung alter und neuer Antiepileptika in der Behandlung psychischer Erkrankungen. Fortschr. Neurol. Psychiat. 63 (1995) 320-335
60. Walden, J., B. Hesslinger, D. van Calker, M. Berger: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 29 (1996) 193-195
61. Walden, J., H. Grunze: Bipolare affektive Störungen. Thieme Verlag, Stuttgart, 1998
62. Young, L. T., R. T. Jofe: Bipolar disorder. Marcel Dekker, New York, 1997